A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZKLJ02 Injection in Healthy Chinese Research Participants
Clinical trial NCT07638098 · COMPLETED
Trial details
- NCT number
- NCT07638098
- Sponsor
- Yunnan Zhongke Longjin Biotechnology Co.,Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-11
- Primary completion
- 2025-11-18
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.